Announced Mon, 6 Jul · 14:55 IST
RTA confirms Regulation 74(5) not applicable for Corona Remedies in Q1 FY27
Compliance View source PDF
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.9%1-day move
₹2040.00
prior close
₹1994.50
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0+0.1+0.8+0.3-2.9-2.6-0.6+0.2+1.0+1.0+2.9———
Up moveDown movePending
AI summary
Corona Remedies has filed a routine SEBI compliance certificate for Q1 FY27 (ended June 30, 2026) under Regulation 74(5) of the Depositories Regulations. The company's Registrar, Bigshare Services, confirmed the regulation does not apply as the entire shareholding is held in demat form and no rematerialization or dematerialization requests were received during the quarter from April to June 2026. This is a standard procedural compliance filing submitted to both BSE and NSE.
Likely market impact
Routine regulatory compliance filing with no effect on share price or shareholders. All shares continue to be held in demat form.